J
Joanna Harnett
Researcher at University of Sydney
Publications - 80
Citations - 921
Joanna Harnett is an academic researcher from University of Sydney. The author has contributed to research in topics: Health care & Medicine. The author has an hindex of 13, co-authored 69 publications receiving 480 citations. Previous affiliations of Joanna Harnett include University of Technology, Sydney & University of Macau.
Papers
More filters
Journal ArticleDOI
Complementary medicine use in the Australian population: Results of a nationally-representative cross-sectional survey.
Amie Steel,Erica McIntyre,Joanna Harnett,Joanna Harnett,Hope Foley,Hope Foley,Jon Adams,David Sibbritt,Jon Wardle,Jane Frawley +9 more
TL;DR: Prevalence of CM use in Australia has remained consistently high, demonstrating that CM is an established part of contemporary health management practices within the general population and it is critical that health policy makers and health care providers acknowledge CM.
Journal ArticleDOI
Community pharmacist's responsibilities with regards to traditional medicine/complementary medicine products: A systematic literature review
TL;DR: The purpose of this study was to determine pharmacist's responsibilities with regards to TM/CM products that have been discussed in the literature since 2000 to take into account three influential factors strategically: the scope of TM/ CM products, objectives of pharmacists' involvement and the perspectives of key stakeholders.
Journal ArticleDOI
Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial
TL;DR: The probiotic formula when taken orally over the 12-week period did not significantly alter the microbiota measured in this population of people with celiac disease, and no statistically significant changes between the groups in the faecal microbiota counts or blood safety measures were revealed.
Journal ArticleDOI
Use of complementary medicine products: a nationally representative cross-sectional survey of 2019 Australian adults
TL;DR: Given the number of Australians using both CM products and pharmaceutical medicines, it is important to evaluate the potential clinical implications of such practices to ensure safe, effective and coordinated health policy and patient care.
Journal ArticleDOI
Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review
TL;DR: There is a paucity of quality research in this area, with indications that the gut microbiota may play a role in fibromyalgia within the emerging field of the gut-musculoskeletal axis.